Cord blood transplantation in aplastic anemia

Bone Marrow Transplantation

Volumn 48, Issue 2, 2013, Pages 201-202

  Peffault De Latour, R ^a   Rocha, V ^a   Socie G ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

aplastic anemia; cord blood; transplantation

Indexed keywords

CD20 ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; BONE MARROW DEPRESSION; CHILD; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FANCONI ANEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCHOOL CHILD; TREATMENT FAILURE; UNRELATED DONORS;

ANEMIA, APLASTIC; CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION CONDITIONING;

EID: 84873471015     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.252     Document Type: Review

References (9)

1. Gluckman E, Wagner JE. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant 2008; 41: 127-132
2. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al. Results of unrelated cord blood transplant in fanconi anemia patients: Risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073-1082
3. Bacigalupo A, Oneto R, Bruno B, Socie G, Passweg J, Locasciulli A et al. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation. Acta Haematol 2000; 103: 19-25
4. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006; 108: 1485-1491
5. Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassi A et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: A report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007; 92: 11-18
6. Maury S, Balere-Appert ML, Chir Z, Boiron JM, Galambrun C, Yacouben K et al. Unrelated stem cell transplantation for severe acquired aplastic anemia: Improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica 2007; 92: 589-596
7. Ruggeri A, Peffault de Latour R, Rocha V, Larghero J, Robin M, Rodrigues CA et al. Double cord blood transplantation in patients with high risk bone marrow failure syndromes. Br J Haematol 2008; 143: 404-408
8. Rocha V, Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol 2009; 147: 262-274
9. Peffault de Latour R, Purtill D, Ruggeri A, Sanz G, Michel G, Gandemer V et al. Influence of Nucleated Cell Dose on Overall Survival of Unrelated Cord Blood Transplantation for Patients with Severe Acquired Aplastic Anemia: A Study by Eurocord and the Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. BBMT 2010; 1: 78-85